2-Methoxyoestradiol-3,17-O,O-bis-sulphamate and 2-deoxy-D-glucose in combination: a potential treatment for breast and prostate cancer.

Tagg, S L C; Foster, P A; Leese, M P; Potter, B V L; Reed, M J; Purohit, A; Newman, S P

Tagg, S L C; Foster, P A; Leese, M P; Potter, B V L; Reed, M J; Purohit, A; Newman, S P.

Affiliation

Tagg SL; Oncology Drug Discovery and Women's Health Group, Faculty of Medicine, Imperial College London, St Mary's Hospital, London W2 1NY, UK.

Br J Cancer ; 99(11): 1842-8, 2008 Dec 02.

Article in En | MEDLINE | ID: mdl-18985042

Subject(s)

Antineoplastic Combined Chemotherapy Protocols/pharmacology; Breast Neoplasms/drug therapy; Prostatic Neoplasms/drug therapy; Animals; Apoptosis/drug effects; Cell Cycle/drug effects; Cell Hypoxia/drug effects; Cell Line, Tumor; Cell Proliferation/drug effects; Deoxyglucose/administration & dosage; Estrenes/administration & dosage; Female; Humans; Immunohistochemistry; Male; Mice; Mice, Nude; Xenograft Model Antitumor Assays

Fulltext

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Prostatic Neoplasms / Breast Neoplasms / Antineoplastic Combined Chemotherapy Protocols Limits: Animals / Female / Humans / Male Language: En Journal: Br J Cancer Year: 2008 Type: Article Affiliation country: United kingdom

Fulltext

XML

PubMed Links

Search on Google